Carcinogenesis, Vol 18, 2113-2117, Copyright © 1997 by Oxford University Press
J Antras-Ferry, K Maheo, M Chevanne, MP Dubos, F Morel, A Guillouzo, P Cillard and J Cillard
Oltipraz (4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione) (OPZ) is
recognized as a potent chemoprotective agent against chemical-induced
carcinogenesis in several animal models and is thought to act mainly by
inducing phase II conjugating together with inhibiting phase I detoxication
enzymes. The present study was undertaken to determine whether oltipraz can
also influence expression of genes encoding antioxidant enzymes. In rat
hepatocytes in primary culture, this compound was found to selectively
induce the transcription of the manganese superoxide dismutase (Mn-SOD)
gene while it had no effect on copper/zinc-SOD and glutathione peroxidase
genes. Oltipraz increased Mn- SOD gene expression in a time- and
dose-dependent manner by 2- to 3- fold and enhanced the binding activity of
the nuclear factor kappa B within 30 min. Moreover, the increase in Mn-SOD
gene transcription was associated with a 2- to 3-fold increase of free
malondialdehyde and conjugated dienes, two markers of lipid peroxidation,
an index of oxidative stress. These results suggest that in rat
hepatocytes, oltipraz induced a production of reactive oxygen species that
probably acted as second messengers in order to trigger the transcription
of many genes. Such a mechanism of action of OPZ and other dithiolethiones
would account for the broad spectrum of action of these anticarcinogenic
compounds.
ARTICLES
Oltipraz stimulates the transcription of the manganese superoxide dismutase gene in rat hepatocytes
Unite INSERM 456 et Laboratoire de Biologie Cellulaire et Vegetale, Faculte des Sciences Pharmaceutiques et Biologiques, Universite de Rennes I, France.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Y. N. Kwon, S. M. Shin, I. J. Cho, and S. G. Kim Oxidized Metabolites of Oltipraz Exert Cytoprotective Effects against Arachidonic Acid through AMP-Activated Protein Kinase-Dependent Cellular Antioxidant Effect and Mitochondrial Protection Drug Metab. Dispos., June 1, 2009; 37(6): 1187 - 1197. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Piton, E. Le Ferrec, S. Langouet, C. Rauch, E. Petit, F. Le Goff, A. Guillouzo, and F. Morel Oltipraz regulates different categories of genes relevant to chemoprevention in human hepatocytes Carcinogenesis, February 1, 2005; 26(2): 343 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Nelson, J. S. Armstrong, S. Moriarty, J. Cai, M.-W. H. Wu, P. Sternberg Jr, and D. P. Jones Protection of Retinal Pigment Epithelial Cells from Oxidative Damage by Oltipraz, a Cancer Chemopreventive Agent Invest. Ophthalmol. Vis. Sci., November 1, 2002; 43(11): 3550 - 3554. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nakamura, K. Okazaki, A. Nishikawa, F. Furukawa, K.-I. Kasahara, M. Miyauchi, T. Imazawa, K. Uchida, and M. Hirose Enhancing Effects of Oltipraz on the Development of Spontaneous Hepatic Lesions in LEC Rats Toxicol Pathol, February 1, 2002; 30(2): 173 - 177. [Abstract] [PDF] |
||||
![]() |
A. Courtois, L. Payen, L. Vernhet, F. Morel, A. Guillouzo, and O. Fardel Differential regulation of canalicular multispecific organic anion transporter (cMOAT) expression by the chemopreventive agent oltipraz in primary rat hepatocytes and in rat liver Carcinogenesis, December 1, 1999; 20(12): 2327 - 2330. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Kim, M. K. Cho, S. H. Choi, H. J. Kim, M. K. Kwak, and N. D. Kim Molecular Basis for Hepatic Detoxifying Enzyme Induction by 2-(Allylthio)pyrazine in Rats in Comparison with Oltipraz: Effects on Prooxidant Production and DNA Degradation Drug Metab. Dispos., June 1, 1999; 27(6): 667 - 673. [Abstract] [Full Text] |
||||



